Insider Transactions in Q4 2023 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.95%
|
$160,000
$20.22 P/Share
|
|
Dec 20
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
40,000
-2.3%
|
$800,000
$20.16 P/Share
|
|
Dec 20
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,252
-50.01%
|
$45,040
$20.0 P/Share
|
|
Dec 15
2023
|
Andrew D. Goldberg Director |
BUY
Open market or private purchase
|
Direct |
1,000
+25.0%
|
$18,000
$18.96 P/Share
|
|
Dec 02
2023
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+41.67%
|
-
|
|
Nov 30
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
8,356
-20.72%
|
$133,696
$16.31 P/Share
|
|
Nov 30
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
8,355
-23.78%
|
$133,680
$16.31 P/Share
|
|
Nov 29
2023
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,920
+37.23%
|
-
|
|
Nov 29
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,920
+40.5%
|
-
|
|
Nov 15
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.3%
|
$144,000
$18.61 P/Share
|
|
Oct 18
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.89%
|
$104,000
$13.24 P/Share
|
|
Oct 05
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,604
-26.26%
|
$28,872
$18.0 P/Share
|